Related content

Elevated levels of CA 19-9 and CEA in pancreatic cancer-associated diabetes

By Guo Qingqu   Kang Muxing   Zhang Bo   Chen Ying   Dong Xin   Wu Yulian  

Journal of Cancer Research and Clinical Oncology, Vol. 136, Iss. 11, 2010-11 ,pp. : 1627-1631

Springer Publishing Company

Access to resources Recommend Favorite

Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine

By Saad Everardo   Machado Marcel   Wajsbrot Dalia   Abramoff Roberto   Hoff Paulo   Tabacof Jacques   Katz Artur   Simon Sergio   Gansl René  

International Journal of Gastrointestinal Cancer, Vol. 32, Iss. 1, 2002-08 ,pp. : 35-41

Humana Press, Inc

Access to resources Recommend Favorite

RE: CA 19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Preoperative Therapy

By Bold Richard  

Annals of Surgical Oncology, Vol. 20, Iss. 7, 2013-07 ,pp. : 2108-2110

Springer Publishing Company

Access to resources Recommend Favorite

CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy

By Hartwig Werner   Strobel Oliver   Hinz Ulf   Fritz Stefan   Hackert Thilo   Roth Constanze   Büchler Markus   Werner Jens  

Annals of Surgical Oncology, Vol. 20, Iss. 7, 2013-07 ,pp. : 2188-2196

Springer Publishing Company

Access to resources Recommend Favorite

A retrospective analysis of early CA19-9 change in salvage chemotherapy for refractory pancreatic cancer

By Nakai Yousuke   Isayama Hiroyuki   Sasaki Takashi   Takahara Naminatsu   Hamada Tsuyoshi   Uchino Rie   Mizuno Suguru   Miyabayashi Koji   Yamamoto Keisuke   Mohri Dai   Kogure Hirofumi   Yamamoto Natsuyo   Hirano Kenji   Ijichi Hideaki   Tateishi Keisuke   Tada Minoru   Koike Kazuhiko  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1291-1297

Springer Publishing Company

Access to resources Recommend Favorite